Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Irinotecan Hydrochloride Trihydrate (Ebewe) 100 mg/5 mL injection, 5 x 5 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Gemcitabine (AS) 2 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Irinotecan Hydrochloride Trihydrate (Sandoz) 100 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Gemzar 200 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Irinotecan Hydrochloride Trihydrate (Mayne Pharma) (irinotecan hydrochloride trihydrate 100 mg / 5 mL) injection, 1 x 5 mL vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ciprofloxacin (Sandoz) 400 mg/200 mL injection, 10 x 200 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Gemcitabine (Ebewe) 1 g/25 mL injection, 25 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Tecan 500 mg/25 mL injection, 25 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Gemcitabine (AS) 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Digibind 38 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Irinotecan (DBL) 100 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Gemcitabine (Sandoz) 200 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Irinotecan Hydrochloride Trihydrate (DP) 40 mg/2 mL injection, 2 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Perfalgan 1 g/100 mL injection, 12 x 100 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Gemcitabine (DBL) 200 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Irinotecan Hydrochloride Trihydrate (Alphapharm) 500 mg/25 mL injection, 25 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Hepatitis B Immunoglobulin-VF (CSL) 100 units injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ciprofloxacin (Sandoz) 100 mg/50 mL injection, 50 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Gemcitabine (Ebewe) 200 mg powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Irinotecan Hydrochloride Trihydrate (Actavis) (irinotecan hydrochloride trihydrate 100 mg / 5 mL) injection, 1 x 5 mL vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Hepatitis B Immunoglobulin-VF (CSL) 400 units injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ciprofloxacin (Sandoz) 200 mg/100 mL injection, 10 x 100 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Gemaccord 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Irinotecan (DBL) 40 mg/2 mL injection, 2 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Sodium Chloride (Phebra) 0.9% (900 mg/100 mL) injection, 100 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Gemcitabine (DBL) 2 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Depo-Nisolone 40 mg/mL injection, 5 x 1 mL vials |
has container type |
False |
vial |
Inferred relationship |
Some |
|
Irinotecan Hydrochloride Trihydrate (DP) 100 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Marcain 0.5% with Adrenaline 1 in 200 000 injection, 5 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Gemcitabine (Sandoz) 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Irinoccord 100 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Gemcitabine (Kabi) 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Depo-Medrol 40 mg/mL injection, 5 x 1 mL vials |
has container type |
False |
vial |
Inferred relationship |
Some |
|
Camptosar 40 mg/2 mL injection, 2 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Marcain 0.25% with Adrenaline 1 in 400 000 injection, 5 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Gemzar 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Tecan 100 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Marcain 0.25% with Adrenaline 1 in 400 000 injection, 5 x 20 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ebegemcit 200 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Irinotecan Hydrochloride Trihydrate (Ebewe) 150 mg/7.5 mL injection, 5 x 7.5 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Marcain 0.5% with Adrenaline 1 in 200 000 injection, 10 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Gemcitabine (AS) 200 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Camptosar 300 mg/15 mL injection, 15 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Pneumovax-23 25 microgram/0.5 mL injection: solution, 0.5 mL vial |
has container type |
False |
vial |
Inferred relationship |
Some |
|
Marcain 0.5% with Adrenaline 1 in 200 000 injection, 5 x 20 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Gemcitabine (Kabi) 200 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Irinotecan Hydrochloride Trihydrate (Ebewe) 40 mg/2 mL injection, 5 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Gemcitabine 2000 (Actavis) 2 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Irinotecan Hydrochloride Trihydrate (Actavis) 500 mg/25 mL injection, 25 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Esmeron 100 mg/10 mL injection, 10 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Gemcitabine (Sun) 200 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Irinotecan Hydrochloride Trihydrate (Baxter) 100 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Esmeron 50 mg/5 mL injection, 12 x 5 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Gemaccord 200 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Irinotecan Hydrochloride Trihydrate (SZ) 100 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Rocuronium Bromide (DBL) 50 mg/5 mL injection, 10 x 5 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Gemcitabine 1000 (Actavis) 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Irinotecan (DBL) (irinotecan hydrochloride trihydrate 500 mg / 25 mL) injection, 1 x 25 mL vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Rocuronium Bromide (Sandoz) 50 mg/5 mL injection, 10 x 5 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Gemcitabine (Ebewe) 200 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Irinotecan Hydrochloride Trihydrate (Ebewe) 100 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Esmeron 50 mg/5 mL injection, 10 x 5 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Gemcitabine (AS) 1 g/100 mL injection, 100 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Irinotecan Hydrochloride Trihydrate (Alphapharm) 100 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Fluorouracil (Ebewe) 500 mg/10 mL injection, 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Gemcitabine (Ebewe) 200 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Fluorouracil (DBL) (fluorouracil 500 mg / 20 mL) injection, 1 x 20 mL vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Irinotecan Hydrochloride Trihydrate (Actavis) 40 mg/2 mL injection, 2 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Fluorouracil (Pfizer (Perth)) 2.5 g/100 mL injection, 100 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Irinotecan Hydrochloride Trihydrate (Baxter) 40 mg/2 mL injection, 2 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Fluorouracil (DBL) 2.5 g/50 mL injection, 50 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Irinotecan Hydrochloride Trihydrate (Kabi) 40 mg/2 mL injection, 2 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Velcade 3.5 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Fluorouracil (DBL) 500 mg/20 mL injection, 10 x 20 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Irinotecan Hydrochloride Trihydrate (GA) 100 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Velcade 1 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Fluorouracil (Pfizer (Perth)) 250 mg/10 mL injection, 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Irinotecan Hydrochloride Trihydrate (SZ) 40 mg/2 mL injection, 2 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Fluorouracil (DBL) 2.5 g/100 mL injection, 10 x 100 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Irinotecan Hydrochloride Trihydrate (Ebewe) 300 mg/15 mL injection, 15 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Fluorouracil (Ebewe) 500 mg/10 mL injection, 5 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Irinotecan Hydrochloride Trihydrate (Kabi) 100 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Fluorouracil (DBL) 500 mg/10 mL injection, 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Camptosar 100 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Robinul 200 microgram/mL injection, 25 x 1 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Fluorouracil (DBL) 1 g/20 mL injection, 5 x 20 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Irinotecan Hydrochloride Trihydrate (Ebewe) (irinotecan hydrochloride trihydrate 150 mg / 7.5 mL) injection, 1 x 7.5 mL vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Robinul 200 microgram/mL injection, 5 x 1 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Fluorouracil (Ebewe) 1 g/20 mL injection, 20 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Robinul 400 microgram/2 mL injection, 25 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Fluorouracil (Ebewe) 5 g/100 mL injection, 100 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Fluorouracil (Ebewe) 2.5 g/50 mL injection, 50 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Fluorouracil (DBL) 2.5 g/100 mL injection, 100 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Fluorouracil (DBL) 500 mg/10 mL injection, 5 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Fluorouracil (Pfizer (Perth)) 500 mg/20 mL injection, 20 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Sustanon 250 injection, 1 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Pantoprazole (Sandoz) 40 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Kadcyla 160 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Kadcyla 100 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Pantoprazole (Sun) 40 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Aldurazyme 500 units/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|